WVE - Wave Life Sciences EPS beats by $0.52 beats on revenue November, 10 2021 07:38 AM Wave Life Sciences Ltd. Wave Life Sciences (NASDAQ:WVE): Q3 GAAP EPS of -$0.12 beats by $0.52. Revenue of $36.42M (+955.7% Y/Y) beats by $26.06M. Press Release For further details see: Wave Life Sciences EPS beats by $0.52, beats on revenue